For the Quarter Ending March 2026
Norfloxacin Prices in North America
- In United States, the Norfloxacin Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- In March 2026, a 3.3% CPI increase and 4.0% retail sales growth supported steady Norfloxacin retail demand.
- The Norfloxacin Production Cost Trend increased in March 2026, directly impacted by a 4.0% rise in PPI.
- An expanding Manufacturing Index and 0.7% industrial production growth in March 2026 reflected steady Norfloxacin compounding activity.
- A 4.3% unemployment rate and 91.8 consumer confidence index in March 2026 sustained Norfloxacin prescription affordability.
- The Norfloxacin Demand Outlook strengthened in February 2026 as North American pharmaceutical antibiotic API demand increased.
- United States natural gas feedstock costs surged in January 2026, elevating energy-intensive synthesis expenses for Norfloxacin.
- United States natural gas feedstock inventories plummeted in January 2026 while net export volumes surged simultaneously.
- The Norfloxacin Price Forecast remained bullish throughout Q1 2026 as healthcare sector antibiotic API production strengthened.
Why did the price of Norfloxacin change in March 2026 in North America?
- United States natural gas feedstock costs surged in January 2026, directly increasing Norfloxacin manufacturing expenses.
- A 4.0% PPI rise in March 2026 elevated intermediate goods costs for Norfloxacin chemical precursors.
- North American pharmaceutical sector demand for antibiotic active pharmaceutical ingredients strengthened significantly in February 2026.
Norfloxacin Prices in APAC
- In China, the Norfloxacin Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream benzene feedstock costs.
- The Norfloxacin Production Cost Trend increased in March 2026 as the producer price index rose 0.5%.
- The Norfloxacin Demand Outlook remained steady in March 2026, supported by a mild 1.0% consumer inflation increase.
- Industrial production grew 5.7% in March 2026, ensuring ample supply availability for the Norfloxacin Price Index.
- Retail sales grew slowly at 1.7% in March 2026, dampening veterinary demand within the Norfloxacin Price Forecast.
- An unemployment rate of 5.4% in March 2026 drove patients toward cost-effective generic Norfloxacin human treatments.
- The manufacturing index expanded in March 2026, reflecting robust production schedules for Norfloxacin active pharmaceutical ingredients.
- Pharmaceutical sector demand for Norfloxacin piperazine feedstock expanded rapidly in the Chinese market during January 2026.
- Pure benzene feedstock costs for Norfloxacin synthesis surged significantly across the Chinese market during March 2026.
Why did the price of Norfloxacin change in March 2026 in APAC?
- Pure benzene feedstock costs for Norfloxacin synthesis surged significantly in the region during March 2026.
- Regional benzene feedstock supply for Norfloxacin tightened as some refineries suspended sales in March 2026.
- Anhydrous ammonia feedstock costs for Norfloxacin intermediates experienced a moderate upward increase during March 2026.
Norfloxacin Prices in Europe
- In Germany, the Norfloxacin Price Index rose quarter-over-quarter in Q1 2026, driven by elevated ammonia feedstock costs.
- The Norfloxacin Production Cost Trend increased during March 2026 as the CPI rose 2.7% year-over-year.
- Upstream precursor costs eased as producer prices declined 0.2% year-over-year in March 2026, supporting manufacturer margins.
- The Manufacturing Index expanded in March 2026, ensuring steady production and supply chain stability for Norfloxacin.
- Industrial production remained stagnant at 0.0% year-over-year in February 2026, constraining supply and supporting the Norfloxacin Price Index.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining baseline Norfloxacin demand.
- The Norfloxacin Demand Outlook faced headwinds as consumer confidence dropped to -24.7 in March 2026.
- The Norfloxacin Price Forecast remained elevated throughout Q1 2026 as pharmaceutical demand for bacterial treatments strengthened.
Why did the price of Norfloxacin change in March 2026 in Europe?
- Elevated global ammonia feedstock prices strengthened production costs for pharmaceutical intermediates in Q1 2026.
- Pharmaceutical demand for bacterial infection treatments strengthened across the regional healthcare sector in Jan 2026.
- A 2.7% consumer price inflation rate increased operational and manufacturing costs during March 2026.
For the Quarter Ending December 2025
Norfloxacin Prices in North America
- In United States, the Norfloxacin Price Index rose quarter-over-quarter in Q4 2025, influenced by rising input costs and robust consumer spending.
- Norfloxacin production costs increased due to a 3.0% year-over-year rise in PPI in November 2025, impacting API manufacturing.
- General inflation, indicated by a 2.7% CPI increase in December 2025, raised raw material and energy costs for Norfloxacin synthesis.
- North American chemical producers maintained a competitive edge from abundant low-cost feedstock throughout 2025, despite rising overall costs.
- Norfloxacin demand was supported by a 2.0% increase in industrial production in December 2025, indicating expanding economic activity.
- Robust consumer spending, with retail sales up 3.3% in November 2025, bolstered human pharmaceutical demand.
- A strong labor market with a 4.4% unemployment rate in December 2025 supported higher disposable incomes, boosting pharmaceutical demand.
- US manufacturing output declined in Q4 2025, while overall industrial production grew, indicating mixed sector signals.
Why did the price of Norfloxacin change in December 2025 in North America?
- Rising input costs, with PPI up 3.0% in November 2025, pressured Norfloxacin production expenses.
- Strong consumer spending, retail sales up 3.3% in November 2025, bolstered pharmaceutical demand.
- Abundant low-cost feedstock throughout 2025 mitigated upward pressure on Norfloxacin production costs.
Norfloxacin Prices in Europe
- In Germany, Norfloxacin Price Index fell in Q4 2025, influenced by declining producer prices in December.
- Norfloxacin production costs decreased in Q4 2025, as Producer Price Index fell 2.5% in December.
- Norfloxacin demand outlook was bearish in December 2025, with consumer confidence at a negative 17.5 index.
- The Manufacturing Index was contracting in December 2025, signaling a slowdown in industrial activity.
- European natural gas prices declined significantly by year-end 2025, easing energy feedstock costs for Norfloxacin.
- German industrial production grew 0.8% year-over-year in October 2025, indicating subdued manufacturing.
- German chemical industry capacity utilization averaged a record low during 2025, suggesting ample Norfloxacin inventory.
- Retail sales grew 1.1% year-over-year in November 2025, providing slight support to overall economic health.
- Stable general prices (CPI 1.8% in December 2025) and 6.2% unemployment indicated mixed economic signals.
Why did the price of Norfloxacin change in December 2025 in Europe?
- Producer prices in Germany fell 2.5% in December 2025, reducing Norfloxacin manufacturing costs.
- Consumer confidence remained negative at -17.5 index in December 2025, indicating bearish demand outlook.
- The Manufacturing Index was contracting in December 2025, reflecting a broader slowdown in industrial activity.
Norfloxacin Prices in APAC
- In China, the Norfloxacin Price Index fell in Q4 2025, influenced by declining factory gate prices.
- Norfloxacin production costs decreased in December 2025, as the Producer Price Index declined by 1.9% year-over-year.
- Norfloxacin demand faced headwinds in December 2025, with retail sales rising only 0.9% year-over-year.
- The Manufacturing Index expanded in December 2025, indicating growth in the pharmaceutical manufacturing sector.
- Industrial production increased by 5.2% year-over-year in December 2025, supporting overall demand for APIs.
- Consumer sentiment cooled in Q4 2025, contributing to moderated consumer healthcare spending.
- The pharmaceutical market in Q4 2025 showed a shift towards biologics, impacting traditional API demand.
- U.S.-China trade conflicts continued to influence pharmaceutical API import dynamics during Q4 2025.
- Economy GDP growth softened in Q4 2025, impacting overall market sentiment and demand.
Why did the price of Norfloxacin change in December 2025 in APAC?
- Producer Price Index declined by 1.9% year-over-year in December 2025, reducing production costs.
- Weak consumer demand, with CPI at 0.8% year-over-year in December 2025, pressured Norfloxacin prices.
- Retail sales growth of 0.9% year-over-year in December 2025 indicated cautious consumer spending.
For the Quarter Ending September 2025
Norfloxacin Prices in North America
- In the United States, the Norfloxacin Price Index fell quarter-over-quarter in Q3 2025, influenced by deteriorating chemical demand.
- Norfloxacin production costs increased in Q3 2025, driven by a 2.6% PPI in August and 3.0% CPI in September.
- The Norfloxacin Price Forecast suggests upward pressure as chemical production costs are expected to accelerate post-Q3 2025.
- Major customer market demand for chemicals and new orders fell in Q3 2025, impacting Norfloxacin demand outlook.
- Chemical inventories shrank in Q3 2025 due to aggressive destocking of raw materials and finished goods.
- U.S. natural gas prices rose significantly in September 2025, increasing Norfloxacin energy costs.
- Consumer confidence declined to 94.2 in September 2025, impacting patient willingness for healthcare spending.
- Industrial production grew only 0.1% in September 2025, reflecting broader economic sluggishness.
Why did the price of Norfloxacin change in September 2025 in North America?
- Deteriorating major customer market demand for chemicals and falling new orders in Q3 2025.
- Rising input, raw materials, energy, and labor costs for chemical manufacturing in Q3 2025.
- The Pharmaceutical Preparation Manufacturing Producer Price Index inched down in September 2025.
Norfloxacin Prices in APAC
- In China, the Norfloxacin Price Index fell quarter-over-quarter in Q3 2025, driven by prevailing deflationary pressures.
- Norfloxacin production costs rose in Q3 2025, influenced by climbing input prices and higher coking coal costs in September 2025.
- China's CPI decreased 0.3% year-on-year in September 2025, contributing to downward Norfloxacin pricing pressure.
- The Producer Price Index fell 2.3% year-on-year in September 2025, indicating lower Norfloxacin factory-gate prices.
- Industrial production grew 6.5% year-on-year in September 2025, supporting Norfloxacin demand across applications.
- Retail sales increased 3.0% year-on-year in September 2025, reflecting stable consumer purchasing power for Norfloxacin.
- A 5.2% unemployment rate and consumer confidence at 89.6 in September 2025 presented mixed signals for Norfloxacin demand.
- Persistent overcapacity in the global chemicals industry during Q3 2025 exerted continued downward pressure on Norfloxacin prices.
Why did the price of Norfloxacin change in September 2025 in APAC?
- Deflationary pressures (CPI -0.3%, PPI -2.3%) in September 2025 impacted Norfloxacin pricing.
- Persistent overcapacity in the global chemicals industry during Q3 2025 created a competitive pricing environment.
- Climbing input prices and higher coking coal costs in September 2025 increased Norfloxacin production expenses.
Europe
- In Germany, the Norfloxacin Price Index remained stable quarter-over-quarter in Q3 2025, despite contracting manufacturing activity.
- Norfloxacin production costs faced pressure from elevated energy prices and 2.4% CPI in September 2025.
- Demand for Norfloxacin was supported by steady pharmaceutical market demand in Germany during Q3 2025.
- The Norfloxacin Price Forecast suggests stability, influenced by a 1.7% year-on-year decline in producer prices in September 2025.
- Norfloxacin production output increased in Q3 2025 compared to Q2 2025, but dropped in August 2025.
- Overall industrial production declined by 1.0% year-on-year in September 2025, impacting raw material availability.
- German imports, including pharmaceutical products, increased substantially in Q3 2025, affecting Norfloxacin trade.
- Consumer confidence at -23.6 index in September 2025 suggests potential weakness in consumer-driven healthcare spending.
- A 3.9% unemployment rate in September 2025 supported stable labor costs and healthcare demand for Norfloxacin.
Why did the price of Norfloxacin change in September 2025 in Europe?
- Producer prices declined by 1.7% year-on-year in September 2025, reducing Norfloxacin input costs.
- Industrial production contracted by 1.0% year-on-year in September 2025, affecting Norfloxacin supply.
- Steady pharmaceutical demand in Q3 2025, alongside increased imports, influenced Norfloxacin market.
